Exploring Precision Medicine & Biotech in Boston (November 2016)

In November 2016, INTO Global Business Communications organized a high-level business delegation to Boston focused on Precision Medicine and Biotechnology. The delegation, comprising executives and investors from leading Chinese Medtech firms like Guosen Securities Research Institute, China Health Industry Investment Fund, Hainan Haiyao (SZSX:000566), Neptunus Galaxy Medicine, and Green Pine Capital, engaged in substantive discussions with key players including Thermo Fisher Scientific, Voyager Therapeutics, Visterra, MassBio, Aquinnah Pharmaceuticals, and Flagship Ventures.

Meeting with Thermo Fisher Scientific

Meeting with Voyager Therapeutics

Meeting with Visterra

Meeting with MassBio

Meeting with Aquinnah Pharmaceuticals

Meeting with Flagship Ventures

中文链接：http://www.intoer.com/archives/1589.html